Rugivan Sabaratnam

Dr. Rugivan Sabaratnam

University of Oxford, Oxford, Oxfordshire, UK
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2023 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
CHCatriona Hilton
Catriona Hilton
RSRugivan Sabaratnam
Rugivan Sabaratnam
HDHal Drakesmith
Hal Drakesmith
FKFredrik Karpe
Fredrik Karpe
A bidirectional relationship exists between adipose tissue metabolism and iron regulation. Total body fat, fat distribution and exercise influence iron status and components of the iron-regulatory pathway, including hepcidin and erythroferrone. Conversely, whole body and tissue iron stores associate with fat mass and distribution and glucose and lipid metabolism in adipose tissue, liver, and muscle. Manipulation of the iron-regulatory proteins erythroferrone and erythropoietin affects glucose and lipid metabolism. Several lines of evidence suggest that iron accumulation and metabolism may play a role in the development of metabolic diseases including obesity, type 2 diabetes, hyperlipidaemia and non-alcoholic fatty liver disease. In this review we summarise the current understanding of the relationship between iron homoeostasis and metabolic disease.


28 January 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
Rasmus KjøbstedRasmus Kjøbsted
Rasmus Kjøbsted
APAndreas J.T. Pedersen
Andreas J.T. Pedersen
JHJanne R. Hingst
Janne R. Hingst
RSRugivan Sabaratnam
Rugivan Sabaratnam
JBJesper B. Birk
Jesper B. Birk
JWJørgen F. P. Wojtaszewski
Jørgen F. P. Wojtaszewski
Current evidence on exercise-mediated AMPK regulation in skeletal muscle of patients with type 2 diabetes (T2D) is inconclusive. This may relate to inadequate segregation of trimeric complexes in the investigation of AMPK activity. We examined the regulation of AMPK and downstream targets ACC-β, TBC1D1, and TBC1D4 in muscle biopsy specimens obtained from 13 overweight/obese patients with T2D and 14 weight-matched male control subjects before, immediately after, and 3 h after exercise. Exercise increased AMPK α2β2γ3 activity and phosphorylation of ACCβ Ser221, TBC1D1 Ser237/Thr596, and TBC1D4 Ser704. Conversely, exercise decreased AMPK α1β2γ1 activity and TBC1D4 Ser318/Thr642 phosphorylation. Interestingly, compared with preexercise, 3 h into exercise recovery, AMPK α2β2γ1 and α1β2γ1 activity were increased concomitant with increased TBC1D4 Ser318/Ser341/Ser704 phosphorylation. No differences in these responses were observed between patients with T2D and control subjects. Subjects were also studied by euglycemic-hyperinsulinemic clamps performed at rest and 3 h after exercise. We found no evidence for insulin to regulate AMPK activity. Thus, AMPK signaling is not compromised in muscle of patients with T2D during exercise and insulin stimulation. Our results reveal a hitherto unrecognized activation of specific AMPK complexes in exercise recovery. We hypothesize that the differential regulation of AMPK complexes plays an important role for muscle metabolism and adaptations to exercise.

4 January 2022 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
RSRugivan Sabaratnam
Rugivan Sabaratnam
JWJørgen F. P. Wojtaszewski
Jørgen F. P. Wojtaszewski
KHKurt Højlund
Kurt Højlund

15 April 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BPBruno Palhais
Bruno Palhais
VPVeronica S. Præstegaard
Veronica S. Præstegaard
RSRugivan Sabaratnam
Rugivan Sabaratnam
TDThomas Koed Doktor
Thomas Koed Doktor
SLSeraina Lutz
Seraina Lutz
BABrage Storstein Andresen
Brage Storstein Andresen
The prevalent c.903+469T>C mutation in MTRR causes the cblE type of homocystinuria by strengthening an SRSF1 binding site in an ESE leading to activation of a pseudoexon. We hypothesized that other splicing regulatory elements (SREs) are also critical for MTRR pseudoexon inclusion. We demonstrate that the MTRR pseudoexon is on the verge of being recognized and is therefore vulnerable to several point mutations that disrupt a fine-tuned balance between the different SREs. Normally, pseudoexon inclusion is suppressed by a hnRNP A1 binding exonic splicing silencer (ESS). When the c.903+469T>C mutation is present two ESEs abrogate the activity of the ESS and promote pseudoexon inclusion. Blocking the 3′splice site or the ESEs by SSOs is effective in restoring normal splicing of minigenes and endogenous MTRR transcripts in patient cells. By employing an SSO complementary to both ESEs, we were able to rescue MTRR enzymatic activity in patient cells to approximately 50% of that in controls. We show that several point mutations, individually, can activate a pseudoexon, illustrating that this mechanism can occur more frequently than previously expected. Moreover, we demonstrate that SSO blocking of critical ESEs is a promising strategy to treat the increasing number of activated pseudoexons.

19 June 2018 in Physiological Reports
Verified
Journal Article
Open access
PDF file
RSRugivan Sabaratnam
Rugivan Sabaratnam
APAndreas J. T. Pedersen
Andreas J. T. Pedersen
JKJonas M. Kristensen
Jonas M. Kristensen
AHAase Handberg
Aase Handberg
JWJørgen F. P. Wojtaszewski
Jørgen F. P. Wojtaszewski
KHKurt Højlund
Kurt Højlund
Acute exercise increases muscle expression and circulating levels of selected putative myokines in patients with type 2 diabetes and weight‐matched controls.